Rare diseases
Investigational molecules
Locations
Back to Czechia14 clinical trials in Chlumec Nad Cidlinou, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
CzechiaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
CzechiaCzechiaA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
CzechiaCzechiaStudy on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
CzechiaCzechiaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
CzechiaStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
CzechiaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
CzechiaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
CzechiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Research focusing on primary prevention of atherosclerotic cardiovascular disease and innovative approaches to prevent heart failure development in high-risk patients.
These trials aim to evaluate new therapeutic combinations for reducing cardiovascular events in at-risk populations.
Investigations into advanced treatments for hypercholesterolemia and innovative therapies targeting lipoprotein management in cardiovascular disease patients.
Studies focus on evaluating novel approaches to achieve optimal lipid levels and improve patient outcomes.
Clinical research examining treatments for acute decompensated heart failure and strategies to reduce cardiovascular mortality in patients with established heart conditions.
These investigations aim to enhance therapeutic options for patients with various forms of heart failure.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
